- Home
- MCRB vs GRWG Comparison
MCRB vs GRWG Comparison
Compare MCRB & GRWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- GRWG
- Stock Information
- Founded
- MCRB 2010
- GRWG 2008
- Country
- MCRB United States
- GRWG United States
- Employees
- MCRB N/A
- GRWG N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- GRWG RETAIL: Building Materials
- Sector
- MCRB Health Care
- GRWG Consumer Discretionary
- Exchange
- MCRB Nasdaq
- GRWG Nasdaq
- Market Cap
- MCRB 156.3M
- GRWG 100.1M
- IPO Year
- MCRB 2015
- GRWG N/A
- Fundamental
- Price
- MCRB $0.84
- GRWG $1.74
- Analyst Decision
- MCRB Buy
- GRWG Hold
- Analyst Count
- MCRB 4
- GRWG 5
- Target Price
- MCRB $5.63
- GRWG $2.75
- AVG Volume (30 Days)
- MCRB 2.4M
- GRWG 726.4K
- Earning Date
- MCRB 11-13-2024
- GRWG 11-12-2024
- Dividend Yield
- MCRB N/A
- GRWG N/A
- EPS Growth
- MCRB N/A
- GRWG N/A
- EPS
- MCRB N/A
- GRWG N/A
- Revenue
- MCRB $126,325,000.00
- GRWG $200,882,000.00
- Revenue This Year
- MCRB N/A
- GRWG N/A
- Revenue Next Year
- MCRB N/A
- GRWG N/A
- P/E Ratio
- MCRB N/A
- GRWG N/A
- Revenue Growth
- MCRB 12856.41
- GRWG N/A
- 52 Week Low
- MCRB $0.54
- GRWG $1.49
- 52 Week High
- MCRB $2.05
- GRWG $3.38
- Technical
- Relative Strength Index (RSI)
- MCRB 47.60
- GRWG 50.96
- Support Level
- MCRB $0.80
- GRWG $1.49
- Resistance Level
- MCRB $1.00
- GRWG $1.62
- Average True Range (ATR)
- MCRB 0.06
- GRWG 0.10
- MACD
- MCRB -0.01
- GRWG 0.01
- Stochastic Oscillator
- MCRB 20.46
- GRWG 61.11
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.